Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

HESTER BIOSCIENCES LTD.

NSE : HESTERBIOBSE : 524669ISIN CODE : INE782E01017Industry : Pharmaceuticals & DrugsHouse : Private

BSE1946.4585.1 (+4.57 %)

PREV CLOSE ( ) 1861.35

OPEN PRICE ( ) 1869.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2830

TODAY'S LOW / HIGH ( )1869.00 2057.75

52 WK LOW / HIGH ( )1246.75 3375.45

NSE1941.8080.8 (+4.34 %)

PREV CLOSE( ) 1861.00

OPEN PRICE ( ) 1851.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1941.80 (5)

VOLUME 30292

TODAY'S LOW / HIGH( ) 1849.80 2070.00

52 WK LOW / HIGH ( )1242.95 3379

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1987

Management Info

Bhupendra Gandhi - Chairman Rajiv Gandhi - Managing Director

Registered Office

Address Meda Adraj , Kadi, , ,
Mehsana,
Gujarat-384441

Phone 079 – 26445106

Email mail@hester.in

Website www.hester.in

Registrars Details

MUFG Intime India Pvt Ltd.

506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad

Listing : BSE, NSE

NEWS

15Jul Hester Biosciences informs about recor
Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosur..

10May Hester Biosciences informs about news
In compliance with Regulation 30 of the SEBI (Listing Obligations and Di..

09May Hester Biosciences informs about outco
Hester Biosciences has informed that Board of Directors, in their Meetin..

09May Hester Biosciences informs about outco
Hester Biosciences has informed that with reference to the letter dated..

09May Hester Biosciences informs about outco
Hester Biosciences has informed that Board of Directors, in their Meetin..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	96.3499999999999	318.42
Gross Profit	114.83	417.6
Operating Profit	147.6	557.08
Net Sales	766.72	2864.66

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE) 9386.25 (2.44%)	M.Cap ( in Cr)23465.63
Neuland Laboratories (BSE) 14496.35 (0.67%)	M.Cap ( in Cr)18598.66
Concord Biotech (BSE) 1921.55 (4.55%)	M.Cap ( in Cr)20102.53
Sanofi India (BSE) 5955.65 (1.12%)	M.Cap ( in Cr)13716.23
Torrent Pharma (BSE) 3504.35 (1.22%)	M.Cap ( in Cr)118603.13

Shareholding Pattern

	PROMOTERS	53.73%
	NON-INSTITUTION	45.75%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Bandhan BSE Healthc...	0.05
Motilal Oswal BSE H...	0.05

Risk Disclosures on Derivatives

Smart Quotes

HESTER BIOSCIENCES LTD.